Scientists at St. Jude are leading research to improve CAR T-cell therapy for osteosarcoma by enhancing chemokine homing. (IMAGE)

St. Jude Children's Research Hospital

Scientists at St. Jude are leading research to improve CAR T-cell therapy for osteosarcoma by enhancing chemokine homing.

Caption

Ashley Chabot, Manager Lab Operations in the Department of Surgery and Lindsay Talbot, MD, Assistant Member in the Department of Surgery, have shown that improved chemokine homing enhances CAR T-cell therapy for osteosarcoma.  

Credit

Courtesy of St. Jude Children's Research Hospital

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.